Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
June 19, 2007
Optimization of novel combi-molecules: identification of balanced and mixed bcr-abl/DNA targeting properties
Zakaria Rachid, Athanasia Katsoulas, Christopher Williams, et al.
Chemical Biology & Drug Design
|
August 6, 2014
Positional isomerization of a non-cleavable combi-molecule dramatically altered tumor cell response profile
Ying Huang, Zakaria Rachid, Lisa Peyrard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 2015
ZRBA1, a Mixed EGFR/DNA Targeting Molecule, Potentiates Radiation Response Through Delayed DNA Damage Repair Process in a Triple Negative Breast Cancer Model
Mitra Heravi, Slawomir Kumala, Zakaria Rachid, et al.
Anti-Cancer Drugs
|
December 13, 2006
Type II combi-molecules: design and binary targeting properties of the novel triazolinium-containing molecules JDD36 and JDE05
Qiyu Qiu, Juozas Domarkas, Ranjita Banerjee, et al.
Cellular Signalling
|
December 9, 2010
The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle
Ranjita Banerjee, Ying Huang, Qiyu Qiu, et al.
British Journal of Cancer
|
September 15, 2004
Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line
R Banerjee, Z Rachid, Q Qiu, et al.
Molecular Cancer Therapeutics
|
April 1, 2010
Subcellular distribution of a fluorescence-labeled combi-molecule designed to block epidermal growth factor receptor tyrosine kinase and damage DNA with a green fluorescent species
Margarita I Todorova, Anne-Laure Larroque, Sabine Dauphin-Pierre, et al.
Bulletin Du Cancer
|
January 7, 2005
[Combi-molecules: a global approach towards better chemoselectivity and chemosensitivity]
Stéphanie Matheson, Qiyu Qiu, Fouad Brahimi, et al.
Frontiers in Oncology
|
June 6, 2019
Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation
Ahmad Chaddad, Michael Jonathan Kucharczyk, Paul Daniel, et al.
Anti-Cancer Drugs
|
July 8, 2009
Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule
Mitra Heravi, Zakaria Rachid, Atta Goudarzi, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
Bioorganic & Medicinal Chemistry Letters
|
June 19, 2007
Optimization of novel combi-molecules: identification of balanced and mixed bcr-abl/DNA targeting properties
Zakaria Rachid, Athanasia Katsoulas, Christopher Williams, et al.
Chemical Biology & Drug Design
|
August 6, 2014
Positional isomerization of a non-cleavable combi-molecule dramatically altered tumor cell response profile
Ying Huang, Zakaria Rachid, Lisa Peyrard, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 2015
ZRBA1, a Mixed EGFR/DNA Targeting Molecule, Potentiates Radiation Response Through Delayed DNA Damage Repair Process in a Triple Negative Breast Cancer Model
Mitra Heravi, Slawomir Kumala, Zakaria Rachid, et al.
Anti-Cancer Drugs
|
December 13, 2006
Type II combi-molecules: design and binary targeting properties of the novel triazolinium-containing molecules JDD36 and JDE05
Qiyu Qiu, Juozas Domarkas, Ranjita Banerjee, et al.
Cellular Signalling
|
December 9, 2010
The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle
Ranjita Banerjee, Ying Huang, Qiyu Qiu, et al.
British Journal of Cancer
|
September 15, 2004
Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line
R Banerjee, Z Rachid, Q Qiu, et al.
Molecular Cancer Therapeutics
|
April 1, 2010
Subcellular distribution of a fluorescence-labeled combi-molecule designed to block epidermal growth factor receptor tyrosine kinase and damage DNA with a green fluorescent species
Margarita I Todorova, Anne-Laure Larroque, Sabine Dauphin-Pierre, et al.
Bulletin Du Cancer
|
January 7, 2005
[Combi-molecules: a global approach towards better chemoselectivity and chemosensitivity]
Stéphanie Matheson, Qiyu Qiu, Fouad Brahimi, et al.
Frontiers in Oncology
|
June 6, 2019
Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation
Ahmad Chaddad, Michael Jonathan Kucharczyk, Paul Daniel, et al.
Anti-Cancer Drugs
|
July 8, 2009
Interaction of ionizing radiation and ZRBA1, a mixed EGFR/DNA-targeting molecule
Mitra Heravi, Zakaria Rachid, Atta Goudarzi, et al.
Page
of 8